Shanghai, China

Qun Dang

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Innovstone Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qun Dang. Retrieved from https://idiyas.com/inventor/qun-dang-tk7zvtjm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qun Dang: Innovator in Anti-Tumor Compounds

Introduction

Qun Dang is an accomplished inventor based in Shanghai, China. She has made significant contributions to the field of anti-tumor research. Although she currently holds no granted patents, her work in developing novel compounds has the potential to impact cancer treatment significantly.

Latest Patent Applications

Qun Dang's latest patent applications include a compound having anti-tumor activity and its use as a PRMT5 inhibitor. The compound is represented by a specific formula and has demonstrated strong inhibitory effects on PRMT5 enzyme activity and tumor cell growth. This makes it a promising candidate for treating PRMT5-mediated diseases. Additionally, the synthesis method for this compound is noted for its simplicity and convenience, which is beneficial for large-scale industrial production and application. Another application focuses on a compound with a novel structure as a PRMT5 inhibitor, emphasizing its strong inhibitory effects and potential for treating diseases mediated by PRMT5 inhibitors.

Conclusion

Qun Dang's innovative work in developing anti-tumor compounds showcases her dedication to advancing cancer treatment. Her research holds promise for future breakthroughs in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…